Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™
Phase 2 data highlight consistent and sustained reductions in Intraocular Pressure (IOP), statistically significant (p<0.0001) through six months, with...
Stay updated with breaking news from Open Angle Glaucoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 2 data highlight consistent and sustained reductions in Intraocular Pressure (IOP), statistically significant (p<0.0001) through six months, with...
Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today...
Did you know glaucoma silently steals sight? Uncover shocking stats and ways to protect your vision! Discover more now.
Glaucoma Awareness Month: Several factors increase the risk of developing glaucoma. Regular eye check-ups, especially for those with risk factors, are paramount, as is awareness because often, it goes undetected in its initial stages.
Glaucoma is a disorder of the eye that gradually steals sight without warning. It is the leading cause of blindness in the United States.